Armata Pharmaceuticals (ARMP) Change in Receivables (2013 - 2017)
Armata Pharmaceuticals' (ARMP) quarterly Change in Receivables came in at -$2000.0 in Q2 2017, down 150.0% year-on-year from $4000.0 in Q2 2016, and up 80.0% quarter-over-quarter from -$10000.0 in Q1 2017.
Armata Pharmaceuticals (ARMP) Change in Receivables (2013 - 2017) Analysis & Trends
Armata Pharmaceuticals has disclosed Change in Receivables across 5 years of filings, most recently posting -$2000.0 for Q2 2017.
- Change in Receivables for Q2 2017 came in at -$2000.0, down 150.0% year-over-year; the trailing twelve-month figure through Sep 2017 was -$11000.0 (up 31.25% YoY), and the FY2020 annual result was $467000.0, changed N/A from the prior year.
- Change in Receivables came in at -$2000.0 for Q2 2017 at Armata Pharmaceuticals, up from -$10000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $129000.0 in Q2 2013 to a low of -$140000.0 in Q4 2013.
- The 5-year median for Change in Receivables is $4000.0 (2014), against an average of -$588.24.
- Across the five-year window, Change in Receivables jumped 152.14% in 2014 and sank 2600.0% in 2015, its largest moves.
- Armata Pharmaceuticals' Change in Receivables stood at -$140000.0 in 2013, then surged by 152.14% to $73000.0 in 2014, then grew by 16.44% to $85000.0 in 2015, then tumbled by 98.82% to $1000.0 in 2016, then slumped by 300.0% to -$2000.0 in 2017.
- The last three Change in Receivables figures came in at -$2000.0 (Q2 2017), -$10000.0 (Q1 2017), and $1000.0 (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -4.08 Mn |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -2,000.00 |
| Jun 30, 2017 | -2,000.00 |
| Mar 31, 2017 | -10,000.00 |
| Mar 31, 2017 | -10,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Jun 30, 2016 | 4,000.00 |
| Jun 30, 2016 | 4,000.00 |
| Mar 31, 2016 | -111,000.00 |
| Mar 31, 2016 | -111,000.00 |
| Dec 31, 2015 | 85,000.00 |
| Dec 31, 2015 | 85,000.00 |
| Sep 30, 2015 | 40,000.00 |
| Sep 30, 2015 | 40,000.00 |
| Mar 31, 2015 | -100,000.00 |
| Mar 31, 2015 | -100,000.00 |
| Dec 31, 2014 | 73,000.00 |
| Dec 31, 2014 | 73,000.00 |